Table 1 Patient characteristics at baseline

From: Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer

 

Treatment group

 

C3

C6

Total

No. of patients

150

147

297

Sex, M/F

104/46

84/63

188/109

Age, median (range)

64 (35–84)

65 (34–83)

64 (34–84)

PS

   

 0

31

26

57

 1

76

74

150

 2

43

47

90

Stage

   

 IIIB

37

34

71

 IV

113

113

226

Histology

   

 Adenocarcinoma

63

66

129

 Squamous cell

46

33

79

 Large cell

15

21

36

 Adenosquamous

3

0

3

 NSCLC – not specified

23

27

50

  1. NSCLC=non-small-cell lung cancer; PS=performance status.
Back to article page